Prognosis of patients with multifocal glioblastoma: a case-control study

Clinical article

View More View Less
  • 1 Center for Neurosurgical Outcomes Research, Maxine Dunitz Neurosurgical Institute, Department of Neurosurgery, Cedars-Sinai Medical Center; and
  • 2 Department of Pathology and Laboratory Medicine, Division of Neuropathology, Cedars-Sinai Medical Center, Los Angeles, California
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

The prognosis of patients with glioblastoma who present with multifocal disease is not well documented. The objective of this study was to determine whether multifocal disease on initial presentation is associated with worse survival.

Methods

The authors retrospectively reviewed records of 368 patients with newly diagnosed glioblastoma and identified 47 patients with multifocal tumors. Each patient with a multifocal tumor was then matched with a patient with a solitary glioblastoma on the basis of age, Karnofsky Performance Scale (KPS) score, and extent of resection, using a propensity score matching methodology. Radiation and temozolomide treatments were also well matched between the 2 cohorts. Kaplan-Meier estimates and log-rank tests were used to compare patient survival.

Results

The incidence of multifocal tumors was 12.8% (47/368). The median age of patients with multifocal tumors was 61 years, 76.6% had KPS scores ≥ 70, and 87.2% underwent either a biopsy or partial resection of their tumors. The 47 patients with multifocal tumors were almost perfectly matched on the basis of age (p = 0.97), extent of resection (p = 1.0), and KPS score (p = 0.80) compared with 47 patients with a solitary glioblastoma. Age (>65 years), partial resection or biopsy, and low KPS score (<70) were associated with worse median survival within the multifocal group. In the multifocal group, 19 patients experienced tumor progression on postradiation therapy MRI, compared with 11 patients (26.8%) with tumor progression in the unifocal group (p = 0.08). Patients with multifocal tumors experienced a significantly shorter median overall survival of 6 months (95% CI 4–10 months), compared with the 11-month median survival (95% CI 10–19 months) of the matched solitary glioblastoma group (p = 0.02, log-rank test). Two-year survival rates were 4.3% for patients with multifocal tumors and 29.0% for the unifocal cohort. Patients with newly diagnosed multifocal tumors were found to have an almost 2-fold increase in the hazard of death compared with patients with solitary glioblastoma (hazard ratio 1.8, 95% CI 1.1–3.1; p = 0.02). Tumor samples were analyzed for expression of phosphorylated mitogen-activated protein kinase, phosphatase and tensin homolog, O6-methylguanine-DNA methyltransferase, laminin β1 and β2, as well as epidermal growth factor receptor amplification, and no significant differences in expression profile between the multifocal and solitary glioblastoma groups was found.

Conclusions

Patients with newly diagnosed multifocal glioblastoma on presentation experience significantly worse survival than patients with solitary glioblastoma. Patients with multifocal tumors continue to pose a therapeutic challenge in the temozolomide era and magnify the challenges faced while treating patients with malignant gliomas.

Abbreviations used in this paper:EGFR = epidermal growth factor receptor; KPS = Karnofsky Performance Scale; MAPK = mitogen-activated protein kinase; MGMT = O6-methylguanine-DNA methyltransferase; PTEN = phosphatase and tensin homolog.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: Chirag G. Patil, M.D., M.S., Center for Neurosurgical Outcomes Research, Maxine Dunitz Neurosurgical Institute, Department of Neurosurgery, Cedars-Sinai Medical Center, 8631 West Third Street, Suite 800E, Los Angeles, California 90048. email: chirag.patil@cshs.org.

* Dr. Patil and Mr. Yi contributed equally to this work.

Please include this information when citing this paper: published online August 24, 2012; DOI: 10.3171/2012.7.JNS12147.

  • 1

    Ampil F, , Burton GV, , Gonzalez-Toledo E, & Nanda A: Do we need whole brain irradiation in multifocal or multicentric high-grade cerebral gliomas? Review of cases and the literature. J Neurooncol 85:353355, 2007

    • Search Google Scholar
    • Export Citation
  • 2

    Batzdorf U, & Malamud N: The problem of multicentric gliomas. J Neurosurg 20:122136, 1963

  • 3

    Claes A, , Idema AJ, & Wesseling P: Diffuse glioma growth: a guerilla war. Acta Neuropathol 114:443458, 2007

  • 4

    Friedman HS, , McLendon RE, , Kerby T, , Dugan M, , Bigner SH, & Henry AJ, : DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 16:38513857, 1998

    • Search Google Scholar
    • Export Citation
  • 5

    Geer CP, & Grossman SA: Interstitial fluid flow along white matter tracts: a potentially important mechanism for the dissemination of primary brain tumors. J Neurooncol 32:193201, 1997

    • Search Google Scholar
    • Export Citation
  • 6

    Hassaneen W, , Levine NB, , Suki D, , Salaskar AL, , de Moura Lima A, & McCutcheon IE, : Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article. J Neurosurg 114:576584, 2011

    • Search Google Scholar
    • Export Citation
  • 7

    Hefti M, , von Campe G, , Schneider C, , Roelcke U, & Landolt H: Multicentric tumor manifestations of high grade gliomas: independent proliferation or hallmark of extensive disease?. Cent Eur Neurosurg 71:2025, 2010

    • Search Google Scholar
    • Export Citation
  • 8

    Jaskólski D, , Zawirski M, , Wiśniewska G, & Papierz W: A case of multicentric glioma of cerebellum and brain. Zentralbl Neurochir 49:124127, 1988

    • Search Google Scholar
    • Export Citation
  • 9

    Kato T, , Aida T, , Abe H, , Ogata A, , Nakamura N, & Nagashima K, : Clinicopathological study of multiple gliomas—report of three cases. Neurol Med Chir (Tokyo) 30:604609, 1990

    • Search Google Scholar
    • Export Citation
  • 10

    Kong DS, , Song SY, , Kim DH, , Joo KM, , Yoo JS, & Koh JS, : Prognostic significance of c-Met expression in glioblastomas. Cancer 115:140148, 2009

    • Search Google Scholar
    • Export Citation
  • 11

    Krex D, , Mohr B, , Appelt H, , Schackert HK, & Schackert G: Genetic analysis of a multifocal glioblastoma multiforme: a suitable tool to gain new aspects in glioma development. Neurosurgery 53:13771384, 2003

    • Search Google Scholar
    • Export Citation
  • 12

    Kyritsis AP, , Bondy ML, , Xiao M, , Berman EL, , Cunningham JE, & Lee PS, : Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst 86:344349, 1994

    • Search Google Scholar
    • Export Citation
  • 13

    Kyritsis AP, , Levin VA, , Yung WK, & Leeds NE: Imaging patterns of multifocal gliomas. Eur J Radiol 16:163170, 1993

  • 14

    Laws ER, , Parney IF, , Huang W, , Anderson F, , Morris AM, & Asher A, : Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467473, 2003

    • Search Google Scholar
    • Export Citation
  • 15

    Lim DA, , Cha S, , Mayo MC, , Chen MH, , Keles E, & VandenBerg S, : Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9:424429, 2007

    • Search Google Scholar
    • Export Citation
  • 16

    Marshall LF, , Jennett B, & Langfitt TW: Needle biopsy for the diagnosis of malignant glioma. JAMA 228:14171418, 1974

  • 17

    Parsa AT, , Wachhorst S, , Lamborn KR, , Prados MD, , McDermott MW, & Berger MS, : Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg 102:622628, 2005

    • Search Google Scholar
    • Export Citation
  • 18

    Salvati M, , Caroli E, , Orlando ER, , Frati A, , Artizzu S, & Ferrante L: Multicentric glioma: our experience in 25 patients and critical review of the literature. Neurosurg Rev 26:275279, 2003

    • Search Google Scholar
    • Export Citation
  • 19

    Scherer HJ: Structural development in gliomas. Am J Cancer 34:333351, 1938

  • 20

    Showalter TN, , Andrel J, , Andrews DW, , Curran WJ Jr, , Daskalakis C, & Werner-Wasik M: Multifocal glioblastoma multiforme: prognostic factors and patterns of progression. Int J Radiat Oncol Biol Phys 69:820824, 2007

    • Search Google Scholar
    • Export Citation
  • 21

    Singh SK, , Clarke ID, , Terasaki M, , Bonn VE, , Hawkins C, & Squire J, : Identification of a cancer stem cell in human brain tumors. Cancer Res 63:58215828, 2003

    • Search Google Scholar
    • Export Citation
  • 22

    Solomon A, , Perret GE, & McCormick WF: Multicentric gliomas of the cerebral and cerebellar hemispheres. Case report. J Neurosurg 31:8793, 1969

    • Search Google Scholar
    • Export Citation
  • 23

    Stupp R, , Mason WP, , van den Bent MJ, , Weller M, , Fisher B, & Taphoorn MJ, : Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987996, 2005

    • Search Google Scholar
    • Export Citation
  • 24

    van Genugten JA, , Leffers P, , Baumert BG, , Tjon-A-Fat H, & Twijnstra A: Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice. J Neurooncol 96:249257, 2010

    • Search Google Scholar
    • Export Citation
  • 25

    Verhaak RG, , Hoadley KA, , Purdom E, , Wang V, , Qi Y, & Wilkerson MD, : Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98110, 2010

    • Search Google Scholar
    • Export Citation

Metrics